The Ovarian Cancer Research Foundation exists because ovarian cancer research has been undervalued and underfunded by successive Governments. Whilst the landscape is changing and more attention is being given to ovarian cancer research, the OCRF provides researchers around Australia and New Zealand with the opportunity to gain access to sustained funding.
The projects selected for funding are in line with the OCRF’s research priorities:
a) Early Detection
- Identifying early events in tumour formation and progression, to help diagnose the presence of ovarian cancer
- Identifying biomarkers that are at a concentration detectable at the early stages of the disease
b) Management & Treatment
- Developing new targets for therapy
- Looking at the best way to beat chemotherapy resistance
- Investigating methods that may block the ability of the cancer to spread
Measuring the “CXCL10 Active Ratio” as a Novel Diagnostic Approach to Ovarian Cancer Detection
Hudson Institute of Medical Research
Tumour-derived Exosomes as a Signature of Ovarian Cancer – Liquid Biopsies as Indicators of Tumour Progression
Centre for Clinical Diagnostics, University of Queensland
Methylated Circulating DNA in Blood for the Early Diagnosis of Ovarian Cancer
School of Women’s and Children’s Health, UNSW
4. Professor Martin K Oehler
Autoantibody Biomarkers for Ovarian Cancer Detection
5. Associate Professor Michelle Hill
Discovery of new blood protein biomarkers to detect ovarian cancer earlier in order to improve prognosis and survival rates
QIMR Berghofer Medical Research Institute
Re-activating Anti-tumour Immunity by Targeting N-MYC-Let7 Axis in Ovarian Cancer